MARKET SEGMENTS Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The Ozempic (semaglutide) segment accounted for the largest market revenue share in 2024
Pharmacokinetic Parameters Clinical Uses Primary treatment of type 2 diabetes mellitus to reduce HbAc Chronic weight management in obesity or overweight individuals with risk factors Reduces risk of major adverse cardiovascular events in high-risk diabetic patients Adverse Effects Common: nausea, diarrhea, constipation, vomiting Less common: injection-site reactions, headache, dizziness Rare risk: pancreatitis
Faisal S, Tariq MH, Abdullah, Zafar S, Un Nisa Z, Ullah R, et al
Patients on combination therapy should monitor glucose levels carefully
If this persists beyond the first two weeks at a new dose, speak to your SheMed clinician
This is why many patients don't realize their injection has degraded until they notice reduced weight loss or appetite-suppressing effects